Corporate Responsibility Report

Overview

The report describes Ascendis Pharma's transition into a fully commercial biopharmaceutical organization, including the U.S. launch of its first commercial product and a workforce of 639 at year-end. It highlights patient advocacy support and establishment of a global Animal Welfare Committee. The company also updated its Code of Business Conduct & Ethics, expanded compliance training, and hosted its first Compliance Week across all locations.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Chapter
Fiscal year: 2021
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services